Company Performance Metrics
Rob Phillips: Founder CEO
Uscom Ltd is an Australian medical device company focused on non-invasive, high fidelity measurement of cardiovascular function. These measurements can be used to assess and manage hemodynamics. Optimizing circulation saves lives and produces better outcomes.
Uscom has two patent protected technologies that provide a comprehensive view of
cardiovascular health.
The USCOM 1A offers real-time, beat-to-beat measurements of 20 parameters of cardiovascular function including cardiac output, stroke volume and systemic vascular resistance with additional parameters such as cardiac power, stroke work and oxygen delivery. The USCOM 1A is unique in being completely non-invasive, validated across a wide range of cardiac outputs in neonates, infants, children and adults, and is soundly patent protected.
CardioScope BP+ is a technology that measures central aortic blood pressure (BP at the heart), peripheral blood pressure (standard upper arm BP), arterial stiffness in the form of peripheral and central augmentation indexes, pulse rate variability and a variety of other measures using supra-systolic oscillometry. There is growing acceptance in the medical community that central and peripheral Pulse Waveform Analysis will become the standard of care in hypertension research and management ranging from the ICU to home care.
Uscom, along with select partners, are developing cloud based solution to assist clinicians and end users to track, analyse, risk score and mange the measurements in easy to use clinical decision support systems and data visualisation tools.
USCOM provides for safe, rapid, accurate and cost effective optimization of circulation.
